Xyall
Xyall
Automated tissue dissection system for global rollout.
About
What does Xyall do?
Xyall is a MedTech startup focused on developing and deploying an automated tissue dissection system. The company has secured significant funding for its global expansion.
What is Xyall's valuation?
StartupHub estimates Xyall's effective valuation at $28.3M (range $19.0M to $45.6M, 20% confidence), based on comparable companies in the sector.
How much funding has Xyall raised?
Xyall has raised a total of $8M in funding. The most recent round on record is Unknown.
Where is Xyall headquartered?
Xyall is headquartered in Eindhoven, North Brabant, Netherlands.
What industry does Xyall operate in?
Xyall operates in Medical Device, Biotechnology, HealthTech.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.